NCT05100940Recruiting
Progress Complication
Prospective Global Registry of Complications of Percutaneous Coronary Interventions
Source: ClinicalTrials.gov · Last updated 19 Aug 2026
Brief summary (registry, in English)
Coronary angiography and percutaneous coronary intervention (PCI) is often performed in patients with ischemic heart disease. The safety of PCI has improved with new devices and strategies, but complications still occur, especially during complex procedures. The objectives of this multi-center observational registry are to examine frequency of complications occuring during cardiac catheterization and PCI, examine procedural strategies utilized for complication management, and evaluate the clinical outcomes (both immediate and during follow-up.)
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 4000 (estimated)
- First submitted
- 4 Oct 2021
- Start date
- 24 Nov 2020
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- Minneapolis Heart Institute Foundation
- Diseases
- Coronary artery disease
- NCT number
- NCT05100940
What you commit to
- Study type: Observational
- Planned participants: 4000
- From 24 Nov 2020 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Over 18 years of age
- undergoing coronary angiography or PCI
- A complication occurred during or after the procedure
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Minneapolis Heart Institute Foundation Coordinator of this site? Confirm its status | Minneapolis | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.